Assura Plc (LON:AGR - Get Free Report) was up 17.5% during mid-day trading on Monday . The company traded as high as GBX 46.20 ($0.59) and last traded at GBX 45.83 ($0.58). Approximately 199,680,109 shares traded hands during mid-day trading, an increase of 1,330% from the average daily volume of 13,966,203 shares. The stock had previously closed at GBX 39 ($0.49).
Assura Trading Up 0.2 %
The stock's 50 day moving average price is GBX 37.88 and its 200-day moving average price is GBX 39.77. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. The stock has a market capitalization of £1.42 billion, a PE ratio of -41.55, a PEG ratio of 3.60 and a beta of 0.37.
Assura Dividend Announcement
The company also recently disclosed a dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, December 12th were paid a GBX 0.84 ($0.01) dividend. The ex-dividend date was Thursday, December 12th. This represents a dividend yield of 2.12%. Assura's dividend payout ratio (DPR) is presently -286.76%.
About Assura
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Featured Articles
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.